Evidence map›Paper›PMID 39143347›Full record

ArticleEuropean journal of pediatrics2024

Schistosomiasis in migrant children and adolescents in a paediatric tropical referral unit in Spain: diagnosis and long-term management challenges.

Paula Rodríguez-Molino, Soraya González Martínez, Jorge Bustamante Amador, Isabel Mellado-Sola, Laura Montes Martín, Iker Falces-Romero, Milagros García López-Hortelano, Jara Hurtado-Gallego, María José Mellado, Carlos Grasa and 1 more

Abstract read
In one paragraph

Article in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paula Rodríguez-Molino *General Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain.
Soraya González Martínez *Health Centre Alameda de Osuna, Madrid, Spain.
Jorge Bustamante AmadorLa Paz Hospital Research Institute (IdiPAZ), Madrid, Spain.
Isabel Mellado-SolaGeneral Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain.
Laura Montes MartínSanitas la Moraleja University Hospital, Madrid, Spain.
Iker Falces-RomeroLa Paz Hospital Research Institute (IdiPAZ), Madrid, Spain.
Milagros García López-HortelanoGeneral Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain.
Jara Hurtado-GallegoLa Paz Hospital Research Institute (IdiPAZ), Madrid, Spain.
María José MelladoGeneral Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain.
Carlos GrasaGeneral Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain.
Talía SainzGeneral Paediatrics, Infectious and Tropical Diseases Department, Hospital La Paz, Madrid, Spain. talia.sainz@uam.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globalisation and population movement have led to an increasing number of migrant children residing in areas non-endemic for schistosomiasis. However, diagnosing and managing schistosomiasis in children remain controversial. This study aims to investigate the prevalence of schistosomiasis in migrant children and to describe the diagnostic approach and management strategies, including long-term follow-up, to explore the potential role of serological tests in evaluating treatment response. We conducted a retrospective descriptive study spanning from January 2014-July 2021 at a referral unit for Paediatric Tropical Diseases in Madrid (Spain). The study included patients under 18 years diagnosed with schistosomiasis. Of 679 children screened for schistosomiasis, 73 (10.8%) tested positive. The median age was 16.3 years [IQR 9-17.6], 74% male. The majority originated from Sub-Saharan Africa (47%) and Asia (47%). Only 40% presented with symptoms, with gastrointestinal (18%) and cutaneous (17%) manifestations being the most common. Eosinophilia was observed in 43% (median [IQR]: 1103/mm3 [671-1536]), and ova were visualised in the urine of 2/50 (4.0%). Praziquantel treatment was administered to 92%, and 5 patients required retreatment. Follow-up data were available for 58 (80%) over a median period of 9 months [IQR 6-19.8], revealing a progressive decline in eosinophil count, IgE titres, and ELISA optical density.    Conclusion: In this series, the prevalence of schistosomiasis among migrant children was significant (10%), highlighting the importance of including serological tests in migrant health screening. The disease is largely asymptomatic, eosinophilia is often absent, and visualisation of ova in urine is exceedingly rare. Eosinophil count, IgE titres, and ELISA optical density could prove valuable as an initial approach for monitoring inflammation during follow-up assessments. What is Known: • The burden of disease related to schistosomiasis is significant, particulary in children, and it is advisable to screen this vulnerable population. What is New: • Eosinophilia may not be present in parasitic infections, so serological tests are crucial for screening migrant children. • Serological monitoring facilitates long-term management of migrant children with schistosomiasis.

Indexed as

AnthelminticsPraziquantelTransients and MigrantsAdolescentChildFemaleFollow-Up StudiesHumansMalePrevalenceRetrospective StudiesSchistosomiasisSpainAnthelminticsPraziquantelChildren and adolescentsMigrantsParasitesSchistosomiasisScreening

Identifiers

PMID39143347
PMCPMC11413142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.